356 related articles for article (PubMed ID: 17320979)
1. Development of a new neutralization test for measles virus.
Fujino M; Yoshida N; Kimura K; Zhou J; Motegi Y; Komase K; Nakayama T
J Virol Methods; 2007 Jun; 142(1-2):15-20. PubMed ID: 17320979
[TBL] [Abstract][Full Text] [Related]
2. [Standardization of neutralization tests using the COBL cell line and comparison with the particle agglutination test for measles serology].
Korukluoğlu G; Yalçinkaya T; Ozkaya E; Kurtoğlu D; Gözalan A; Miyamura K
Mikrobiyol Bul; 2002 Apr; 36(2):193-9. PubMed ID: 12652872
[TBL] [Abstract][Full Text] [Related]
3. In vitro effect of haemagglutination inhibition antibodies on measles virus replication.
Odama LE; Eghafona NO; Emejuaiwe SO
Microbios; 1985; 43(174-175):181-3. PubMed ID: 4094569
[TBL] [Abstract][Full Text] [Related]
4. [Comparison between the plaque reduction neutralization test and the hemagglutination inhibition test in determination of human anti-measles antibodies].
Kong J; Guo SH; Ze WY
Zhonghua Liu Xing Bing Xue Za Zhi; 1996 Apr; 17(2):105-7. PubMed ID: 8758407
[TBL] [Abstract][Full Text] [Related]
5. Measles immunity testing: comparison of two measles IgG ELISAs with plaque reduction neutralisation assay.
Cohen BJ; Parry RP; Doblas D; Samuel D; Warrener L; Andrews N; Brown D
J Virol Methods; 2006 Feb; 131(2):209-12. PubMed ID: 16188328
[TBL] [Abstract][Full Text] [Related]
6. An improved plaque reduction virus neutralization assay for human metapneumovirus.
de Graaf M; Herfst S; Schrauwen EJ; van den Hoogen BG; Osterhaus AD; Fouchier RA
J Virol Methods; 2007 Aug; 143(2):169-74. PubMed ID: 17420056
[TBL] [Abstract][Full Text] [Related]
7. Comparison of plaque reduction neutralisation test (PRNT) and measles virus-specific IgG ELISA for assessing immunogenicity of measles vaccination.
Cohen BJ; Doblas D; Andrews N
Vaccine; 2008 Nov; 26(50):6392-7. PubMed ID: 18834911
[TBL] [Abstract][Full Text] [Related]
8. Measles immunity and response to revaccination of a young adult population in Israel.
Mendelson E; Duvdevani P; Varsano N; Lerman Y; Slepon R; Dagan R; Cohen D; Danon Y; Shohat T
J Med Virol; 1996 Nov; 50(3):249-53. PubMed ID: 8923290
[TBL] [Abstract][Full Text] [Related]
9. [Gelatin particle agglutination (PA) antibody: comparison to neutralizing antibody (NT) and hemagglutination inhibition (HI) antibody and relationship to IgG avidity].
Saika S; Matsunaga T; Ogawa T; Ichinohe S
Kansenshogaku Zasshi; 2008 Jul; 82(4):310-6. PubMed ID: 18697482
[TBL] [Abstract][Full Text] [Related]
10. Neutralization enzyme-linked immunosorbent assay for evaluation of immunity to measles virus.
Nates SV; Rey GY; Giordano MO; Depetris AR; Boshell J
Viral Immunol; 1995; 8(1):47-52. PubMed ID: 8546804
[TBL] [Abstract][Full Text] [Related]
11. [Study on the neutralization capacity of different types of human measles virus vaccine and the epidemic strains].
Feng Y; Lu YY; Yan JY; Jiang XH; Shi W; Xu CP; Li Z
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Nov; 28(11):1123-6. PubMed ID: 18396671
[TBL] [Abstract][Full Text] [Related]
12. Rapid human metapneumovirus microneutralization assay based on green fluorescent protein expression.
Biacchesi S; Skiadopoulos MH; Yang L; Murphy BR; Collins PL; Buchholz UJ
J Virol Methods; 2005 Sep; 128(1-2):192-7. PubMed ID: 15955576
[TBL] [Abstract][Full Text] [Related]
13. Role of virus strain in conventional and enhanced measles plaque neutralization test.
Albrecht P; Herrmann K; Burns GR
J Virol Methods; 1981 Dec; 3(5):251-60. PubMed ID: 7334066
[TBL] [Abstract][Full Text] [Related]
14. Development of a high-throughput assay for measuring serum neutralizing antibody against enterovirus 71.
Huang ML; Chiang PS; Luo ST; Liou GY; Lee MS
J Virol Methods; 2010 Apr; 165(1):42-5. PubMed ID: 20036286
[TBL] [Abstract][Full Text] [Related]
15. Induction of broadly neutralizing antibodies against measles virus mutants using a polyepitope vaccine strategy.
Bouche FB; Steinmetz A; Yanagi Y; Muller CP
Vaccine; 2005 Mar; 23(17-18):2074-7. PubMed ID: 15755573
[TBL] [Abstract][Full Text] [Related]
16. [A study on measles immune status by ELISA].
Li GQ
Zhonghua Liu Xing Bing Xue Za Zhi; 1989 Apr; 10(2):105-8. PubMed ID: 2736614
[TBL] [Abstract][Full Text] [Related]
17. The significance for epidemiological studies anti-measles antibody detection examined by enzyme immunoassay (EIA) and plaque reduction neutralization test (PRNT).
Siennicka J; Częścik A; Trzcińska A
Przegl Epidemiol; 2014; 68(3):417-20, 527-9. PubMed ID: 25394302
[TBL] [Abstract][Full Text] [Related]
18. [Immunologic tests: Measles virus].
Kawamura M
Nihon Rinsho; 2005 Jul; 63 Suppl 7():359-62. PubMed ID: 16111274
[No Abstract] [Full Text] [Related]
19. Enzyme-linked immunosorbent assay (ELISA) for measles antibody. A comparison with haemagglutination inhibition, immunofluorescence and plaque neutralization tests.
de Souza VA; Pannuti CS; Sumita LM; Albrecht P
Rev Inst Med Trop Sao Paulo; 1991; 33(1):32-6. PubMed ID: 1843394
[TBL] [Abstract][Full Text] [Related]
20. Immunosorbent assay based on recombinant hemagglutinin protein produced in a high-efficiency mammalian expression system for surveillance of measles immunity.
Bouche F; Ammerlaan W; Berthet F; Houard S; Schneider F; Muller CP
J Clin Microbiol; 1998 Mar; 36(3):721-6. PubMed ID: 9508302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
